{"name":"Teijin Pharma Limited","slug":"teijin-pharma-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxQenpnQ2dacmJnWGEwY3h3bmJJZkFSVnJmS05qeHNYcDNCM05QX3RnWVpkVjRCaElHbkpXLTdNV1IyM0VZMWFzVHJDQmtic2kwbjBVWU1EVTdfNWJEY0ZyeHhrdnRNdFVjNWpRS2hrNVg0Mkk4TGVWZjM1MklIRjViUW9XRXN6WXBtdXBXMnZ1NWRrVzZUbDV6czliZUUxUndnalRGNTZ6YXMyc3V1QUo0b01wd0lPaElMVXRDNVRXS01qcXIxeHJzWEo3bVJZeGs?oc=5","date":"2026-03-31","type":"earnings","source":"TipRanks","summary":"Teijin Slashes FY2026 Profit Outlook on Pharma Impairment and Tax Asset Write-Down - TipRanks","headline":"Teijin Slashes FY2026 Profit Outlook on Pharma Impairment and Tax Asset Write-Down","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQd2g1M1RYLWtUa1YzbS1VUFBscWFRYWg2TFJjTWFLWXIxaG9tUXBhTjYxVnBLSW1CNmVSdUlXSEZ3VDZSdnZPXzNGX003a19YNzRQR2FWMGg3bDI4OGs1aE1lZktOdzMxQWNvSEFvU25MWVpkSG9mNERwX2xZMkQ1LUJsQ3hOeFB2YUxvbXdsQmstRFhzZTBxY0hzdVZ0UzRGM1Jaa0VmLWx5OEd5T0lzQlZLV1J6NDF0NGpRc3BWRWNMN0ZBQWJUTk11eWVLTEJLbXZB?oc=5","date":"2026-02-18","type":"deal","source":"Femtech Insider","summary":"Teijin Pharma and Aska Pharmaceutical Partner to Discover New Small-Molecule Drugs for Gynecological Diseases - Femtech Insider","headline":"Teijin Pharma and Aska Pharmaceutical Partner to Discover New Small-Molecule Drugs for Gynecological Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPWE40a1Nma2U0aldrT2ZlblFiYzJmTzlBOFBYMEF6U2tWTmVzVURuNnpZRHd2akRtWXB1YUg3TWs4Wk5HdDhnaVlnVkw4QkEwdE9nYy1fQUlLdFI1aHJELUV1ekRNY2JZbElZVVQzekVKYTE0NnFVVUk4NFk0Wi1SSEU3NC15V290TUtwUlF5S1JVMWRGSk9CbTVRWHpwZjN6ZGVRSVFyTVY0Y3RJRlZj?oc=5","date":"2026-02-10","type":"pipeline","source":"BioWorld News","summary":"Teijin Pharma and Transthera Biosciences report new ALOX15 inhibitors - BioWorld News","headline":"Teijin Pharma and Transthera Biosciences report new ALOX15 inhibitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE91RExBQnVGSGI4OTRWUjJUR0hib1Niek9MSkxsdUJtSjl2d09XNEVPU0VaTVJxVWg3WDlVSXJuQVlKTnpocmtXNUhpLUt6QXpxNVMzY0J5SWdxa1pmVW9sejNLcw?oc=5","date":"2025-10-16","type":"pipeline","source":"Wiley Online Library","summary":"Clinical obesity and Himan-sho (obesity disease): Lessons from Japan's 25 years of experience toward a new era of obesity care - Wiley Online Library","headline":"Clinical obesity and Himan-sho (obesity disease): Lessons from Japan's 25 years of experience toward a new era of obesit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPNEx3eVdsSzFHVi1MSUxRenZ3TnlNbHBoSVhmVFBEYnJ3V3FIX1d5TlFFNnRqSnJWZTUxc1A1V3hyQnFIYUxfcXRxMHQ1b2x4bHpNWVRGTjNwci1SQ2FLZlVpQUowdHptTkVIQnpqdTNVWk95ck45aUdfRlBYdUo1d1ozQWxEajB5RGxoTWxnNkl5Y0VGZlBYYXMzeERSR1JVZ1B3dkVOREk2TXVNWWxMTFc4RW9iWkNwVWVIYWVrY0VCX2htU3NreHFGS3NvVFRBTk52TnZQTFFYVTlyYW1kaHRteWIyQTl1ZEpMc24yRkstUktTdUg5YzVXdFlVeldVMXFMY1NOZ1o?oc=5","date":"2025-09-16","type":"trial","source":"globenewswire.com","summary":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight - globenewswire.com","headline":"Gout Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in Gout Therapeutics | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wJBVV95cUxPU3RGMlFjcVVhSnVqOE1mbUlPNEtjOEU2V1hlNG05czhRZ3B1MkZRY0pTTHR5UEFqQTlJUnYyOUI1N0lodDl5N1V2S1NRQ0VmdkdVVTRHa1hpTmVPeTZ3eUVlV1lFREV1ZlFkMmpPZkZ5WWFCSDFQSU8wdER1ZXI2R25LWl80Q3ZGVm9OU24xd2I0VENzcVlUc0NlUHhZektWNldUR01ZNUdlYTNyNV9uLUJvUjc5dXBDMU1YTTlYeFNPVVFSRHRPLUgxQVRFZ2tSVWpTVlk1MGg4WTdDTzBnVXh0NV9ELW5sVFlBNG5IdzJsX0JvWkZoRkx6eThJRHRZQmUxMXZkYlFnMzZCX1p3X2x6U3hEUE90eERTZmwyV1Fhd2R2a2lMT184UVMzckdjNFVscENEMUFzbjdJaUgyUzBYcG5SRUk3V0w4dWhBTVhNWVU?oc=5","date":"2025-03-31","type":"regulatory","source":"Barchart.com","summary":"Rheumatoid Arthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Eli Lilly and Company, Philogen, I-Mab Biopharma Co. Ltd., Teijin Pharma -","headline":"Rheumatoid Arthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQejYwbWVYQlllLXJVWXZQTi1tVlhqUXhkcVNJTnI4WjZOWUJQZGhTbWJfTnJQVDRhYm1lNGQxcVlqMzM4dmMyUDFWOW5QTmoxMHVrOENfNmFNcHpiVDd3X1FadUQ3OXdoS0ROQWVha25PYmJPb2E3MTFrUVJPZ2pjcjZiYXJUaEVwYkEtbzdVSzdPdWxQNmJ0bDB3?oc=5","date":"2024-06-07","type":"pipeline","source":"The Worldfolio","summary":"News Release: Toward Dissemination of Digital Therapeutics - The Worldfolio","headline":"News Release: Toward Dissemination of Digital Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNS1A3UnRGSU5ScDlwR2Q0NzMwaDlvMEFPM08tak1Yc1VtUXhlTks1cjdBaElSZm9xTl9FRDFOa004NGRPejRTcG96SmNhem5UVHVzREdMbGw5azFsWFNRQVk1RUd5RE9kNXF6YlRacmYtT001VlhGMTkxellMRUd1OUVhTDI2UG10V3dBdmhEX3VOTUdsWG04eHNFVHBoTC1lSDNR?oc=5","date":"2021-04-26","type":"pipeline","source":"pharmaphorum","summary":"Jolly Good/Teijin Pharma develop VR digital therapeutics for depression - pharmaphorum","headline":"Jolly Good/Teijin Pharma develop VR digital therapeutics for depression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxObmpHVmNaQzdCWUJWR1huXzdGOEl6Zm9YTUJ0MldqNmVBRDhHT3hpMkNFUDJ4RV93dG0zbUdWTTRLeEJBU2tSdHpuTWlodndBbkx4emp1eWo2R0plczFHSDc1WWV3S0hsSUFfWnRTTVVKSEQxamU5a2Jtb0lBOVh1bmw0eHN4ZW1lNjRjNg?oc=5","date":"2021-04-01","type":"pipeline","source":"Pharmaceutical Technology","summary":"Takeda sells Japan’s non-core products portfolio to Teijin Pharma - Pharmaceutical Technology","headline":"Takeda sells Japan’s non-core products portfolio to Teijin Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNSThuVUpjZnZNazhmZ1BvT3IxSkVlUmwxcUVFTVNsNVZrRTkwOWk2aUJIYjVlNkp6QTdxU2tDTkRDdWNOTkNGZXBDM2xzOUhDclBLekZuT18wREpRNmZobENfeWV3cExSeUp4LU9yMFdCMlZjSjllNU13cnJVSmVORkRndTJVdjJqRkNaOF82ZEtlbVZjR2hDcTdJZndBODlrY3ZBbGp6eGd1b3pvbVNfZVhnQnMxZnM3b1VwREpnb2ROUEEyN1JzZFdmRGsxYlRXd2c?oc=5","date":"2021-02-26","type":"pipeline","source":"Reuters","summary":"Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 bln - Reuters","headline":"Japan's Takeda sells four diabetes products to Teijin Pharma for $1.25 bln","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNNks0OEF1Qk9jYU5NdVhsUy1wV3VudGc0OV9GNlIzOWFzUnd5YXZJSzBDZUQyNzN6Zy1zajhmOUJLcW13c1VlVUFacnZTbUQzbW5yNWVBZmQwazdmdXBQNW5oTVJ1aXRYd0xVOHI5X0Q4UU5CQUg5NmxrMzdzSDhaTGt3aWRJWTE1Yll6TXI5RWJmbDRNSDR2QzhVTWpLajRNZkxZRDR1NA?oc=5","date":"2019-05-17","type":"pipeline","source":"Nutraceutical Business Review","summary":"Japanese Teijin pharma enters the functional foods market - Nutraceutical Business Review","headline":"Japanese Teijin pharma enters the functional foods market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOLW5oUUktYmJzUVZHZDJYZFIwNFVrVFBWcnR2RTFqQlQ5TklBREJ6TWhNMk1JMUdFdmx1QnVTNjlhSDcxdHBYenpYVGVxMlFDU19ZS21aSnFocW5HbXgxVmdSNjdfUDNEQWd5WGVWRk9GeE1jSkd6RUJrLWZ5Q3VTOWFpRDVvS28waEJKSmYxQ0lHLXR4WmlhZExyOFBDSk9sUmM4SmtVT1d6WlFvak1sODZQd1lLOGFTSmdTc0RMSTNpT3V1NUZj?oc=5","date":"2017-01-26","type":"trial","source":"dicardiology.com","summary":"Bristol-Myers Squibb Enters Collaboration with Nissan Chemical, Teijin Pharma on Atrial Fibrillation Compound - dicardiology.com","headline":"Bristol-Myers Squibb Enters Collaboration with Nissan Chemical, Teijin Pharma on Atrial Fibrillation Compound","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}